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Genetics of the Multiple Endocrine Neoplasia 1ype 2B Syndrome 
Charles E. Jackson,* and Robert A. Norumt
Multiple endocrine neoplasia type 28 (MEN 28) is similar to MEN 2A in that both autosomal 
dominant syndromes include medullary thyroid cancers and pheochromocytomas. It is distinct in that 
MEN 28 patients have much earlier age of onset with more aggressive tumors and mucosa/ neuromas 
of the lips and tongue. The neuromas allow ascertainment generally before age 5. Studies of two and 
three generations of 14 MEN 28families disclosed close linkage of the MEN 28 gene to DNA markers 
to which MEN2A had been linked.Multipoint analysis utilizing additional results in three generations 
of a 15th family have disclosed a peak Lota/ loci score of 8.89 at Lhe midpoint between the centromere 
markers DLOZJ and R8P3 on the long arm (band ql ). One recombinant was observed between 
DIOZJ and MEN28, but this individual was not recombinant with DJOS94. These studies suggest 
physical proximity of MEN2A and MEN28 bur do not establish a/le/ism for the gene(s ). (Henry Ford 
Hosp Med J 1992;40:232-5) 
Multiple endocrine neoplasia type 2B (MEN 2B) is a syn­drome in which medullary thyroid cancer (MTC) is asso­
ciated with adrenal medullary pheochromocytomas and mu­
cosa] neuromas. MEN 2B is distinguished from MEN 2A by the 
presence in MEN 2B of neuromas of mucous membranes such 
as shown in Fig l (I), intestinal ganglioneuromas, and generally 
by the lack of parathyroid involvement (2-7). In addition, the 
MEN2B MTCs have an earlier onset and are generally (7-9), but 
not necessarily (10), more aggressive. Thickened corneal nerves 
(11) and skeletal abnormalities are also observed in MEN 2B
frequently with a marfanoid habitus and arachnodactyly. Both
MEN 2A and 2B have an autosomal dominant inheritance with
a greater proportion of MEN 2B cases arising as new mutations.
The gene for MEN 2A (MEN2A) has been localized to chro­
mosome 10 by Mathew et al (12) and by Simpson et al (13) with 
confirmation by many other studies in diverse populations ( 14-
l 9). ln these studies no suggestion has been reported yet of ge­
netic heterogeneity even for variant families in whom the whole 
spectrum of tumor involvement is not seen or even in those fam­
ilies of MTC only (20,21). 
Studies of Norum et al (22) in two and three generations of 14 
MEN 2B families established that the gene for MEN 2B 
(MEN2B) is closely linked to the same DNA markers to which 
MEN2A has been Linked. Additional results in three generations 
of a 15th family (Fig 2) add data to confirm this localization with 
a peak total lod score of 8.89 at the midpoint between the cen­
tromere and RBP3 on the proximal long arm of chromosome 10 
[Fig 3, (23)]. Table l shows the two-point linkage data between 
MEN2B and chromosome 10 markers. Lairmore et al (21) re­
ported confirmation of this localization in six MEN 2B families, 
two of which had been those utilized in the study of Norum et al 
(22). The combined two-point linkage data are shown in Table 
2. 
In one family (Fig 4) linkage data provided evidence that 
MEN2B is on the proximal long arm of chromosome 10 since a 
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recombinant was observed between the centromere marker 
DIOZl and MEN2B and DIOS94 (24) on the telomeric side of 
the long arm. This one family also provided evidence that the 
new mutation in this family was paternal in origin. Studies of 
three other new mutation cases showed the mutation to be pater­
nal in one other family and maternal in two. ln MEN 2B the 
availability of new mutation cases in whom DNA has been ob­
tainable from both unaffected parents will be important in iden­
tifying the gene when possible candidate genes are ascertained. 
New mutation cases have been important in identifying the gene 
for neurofibromatosis type 1 (25). The availability of many new 
mutation cases is one of the advantages of studying MEN 2B. 
Another advantage is that the diagnosis of MEN 2B is evident at 
an early age by experienced parents or physicians by its pheno­
typic expression of the first mutational event (Fig 5). 
We have suggested a contiguous gene theory as an explana­
tion for the observation that the tissues involved with MEN 2 tu­
mors are generally consistent within families with a variety of 
tumor involvement between families (20,26,27). The linkage of 
MEN2B to the same DNA markers to which MEN2A has been 
linked is compatible with this theory and the initiation of the 
MEN 2 tumors by the possible deletion of tumor-suppressor 
genes as in the retinoblastoma model. However, no chromo­
some 10 deletions were observed in high-resolution cytogenetic 
studies of 16 MEN 2A and 7 MEN 2B families (28). Also, no 
consistent chromosome IO losses of heterozygosity in MEN 2A 
tumors have been observed (20,29-32) as in the retinoblastoma 
model. Losses of heterozygosity of lp  have been reported in 
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Fig 1-A) (top photo) Illustration of mucosa/ neuromas of 
tongue from 1923 publication by Froboese ( 1) (reprinted with 
permission, copyright© Springer-Verlag). B) (bottom photo) 
Bumpy lips and tongue of 20-year-old new mutation MEN 2B 
case. 
MEN 28 tumors (33). The cause of the tissue specificity in 
MEN 2 and in other hereditary tumors such as the Beckwith­
Weidemann syndrome (34) will remain an area of speculation 
until more knowledge is obtained on the nature of the genes in­
volved (20). 
The linkage data presented here indicate that MEN2B and 
MEN2A are closely linked to the same DNA markers but do not 
indicate that the gene(s) are allelic (22). Elucidation of the na­
ture of the gene(s) may provide an understanding of the etiology 
of the mucosa! neuromas, the ganglioneuromas, the marfanoid 
habitus, and the other unique phenotypic changes of MEN 28 as 
well as an explanation for the aggressiveness of the tumors of 
MEN 2B. 
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FNRB 
DIOZI 
RBP3 
D10Sl5 
Table I 
Pairwise Linkage MEN2B Versus Markers 
0 
3.43 
6.41 
-1.51
0.63
0.05 
3.69 
6.35 
1.50 
3.74 
0.1 
3.44 
5.75 
1.44 
3.48 
Mul1ipoin1 peak LOD score 8.89 at the midpoi111 between D IOZI and RBP3. 
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DIOZl(EcoRV) + + + 
D!OS94(Pvu!J) 1.2 1,2 1,2 1,2 1,2 1,2 1,2 I 1.2 1.2 I 
MCK2(Rsal. Mspl) not informative 
RBP3(Mspl, Bglll) not informative 
D!OS5(Taql) not informative 
Fig 2 -Pedigree of three generations of the 15th MEN 2B family 
studied with data on DJOS94 (24), FNRB, and DJOZJ. The 
D10S94 data were kindly provided by P. J. Goodfellow. 
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Fig 3-lllustration of the location of MEN2B in reference to 
pericentromeric DNA markers. The physical map of chromo­
some IO has been modified from Smith & Simpson (23 ). The 
longer arrow indicates the likely location of MEN2A, and the 
shorter arrow indicates the location of MEN2B based on the 
crossover observed between MEN2B and the centromere 
marker DJOZJ. 
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ii o ii
FNRB F2 Fl/F2 F2 Fl/F2 F2 F2 F2 
Dl0Zl(Bg1II) 1600 580 580 580 
580 580 580 580 
DI OZI (Seal) 570 570 570 570 
420 570 570 570 
DIOS94 A2 Al Al Al/A2 AI/A2 Al AI/A2 
I. Crossover with FNRB and D10ZI on one side, and DIOS94 and MEN2B on 1he other
side.2. The new mutation was paternal.
Fig 4-Pedigree and linkage data on the family in which a re­
combinant is observed between the centromere marker DJOZJ 
and MEN2B and DJOS94 telomeric to the centromere on the 
long arm. The DJOS94 studies were kindly performed by P. J. 
Goodfellow. 
Fig 5-lllustration of affected mother and infant son dem­
onstrating the identification of MEN 28 individuals at young 
ages. In this family it was later possible to identify that a daugh­
ter was affected at birth. 
2B families (22), to Dr. G. W. Sizemore of Chicago, IL, and Dr. 
S. Khosla of Rochester, MN, for providing access to the l5th
family reported here (35), and to the cooperation of the many
MEN 2B patients and their families.
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